Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

roche.com

Roche Media News

Get the latest updates from Roche Media News directly as they happen.

Follow now 321 followers

Latest posts

Last updated 1 day ago

Roche data at ESMO 2025 showcase advances in science and cancer care across multiple tumour types

1 day ago

Basel, 13 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced...

Change in the Roche Board of Directors

11 days ago

Basel, 3 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced...

Data show Roche’s sixth-generation Troponin T test offers a new level of accuracy critical for diagnosing heart attacks

14 days ago

Recently granted CE Mark, the novel test delivers improved sensitivity and accuracy...

Roche presents new data for OCREVUS and fenebrutinib across broad patient populations at ECTRIMS 2025

20 days ago

OCREVUS subcutaneous maintains consistent benefit-risk profile after two years New late-breaking data...

Positive phase III results show Roche’s giredestrant significantly improved progression-free survival in ER-positive advanced breast cancer

22 days ago

evERA met its co-primary endpoints; giredestrant plus everolimus demonstrated significant benefit in...

CHMP recommends EU approval of Roche’s subcutaneous formulation of Lunsumio for people with relapsed or refractory follicular lymphoma

25 days ago

Lunsumio provides high and long-lasting response rates, with approximately two-thirds of patients...

Roche enters into a definitive merger agreement to acquire 89bio, and its phase 3 FGF21 analog for the therapy of moderate to severe MASH

26 days ago

89bio’s pegozafermin allows for a potentially best-in-disease treatment for moderate to severe...

New data for Roche's Vabysmo reinforce its efficacy, safety and durability in neovascular or “wet” age-related macular degeneration (nAMD)

about 1 month ago

In AVONELLE-X, the largest long-term extension trial in nAMD, disease control and...